Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fetal valproate syndrome.

Literature DB >> 17090909

Fetal valproate syndrome.

M L Kulkarni¹, M Zaheeruddin, Nivedita Shenoy, H N Vani.

Abstract

Fetal Valproate Syndrome results from prenatal exposure to valproic acid. It is characterized by distinctive facial appearance, a cluster of minor and major anomalies and central nervous system dysfunction. Here we report a 4-year-old boy with typical facial features of Fetal Valproate Syndrome.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2006 PMID： 17090909 DOI： 10.1007/bf02859291

Source DB: PubMed Journal: Indian J Pediatr ISSN： 0019-5456 Impact factor: 1.967

14 in total

1. Fatal cardiac malformation in fetal valproate syndrome.

Authors: P Sodhi; B Poddar; V Parmar
Journal: Indian J Pediatr Date: 2001-10 Impact factor: 1.967

2. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.

Authors: E Jäger-Roman; A Deichl; S Jakob; A M Hartmann; S Koch; D Rating; R Steldinger; H Nau; H Helge
Journal: J Pediatr Date: 1986-06 Impact factor: 4.406

3. Valproate, birth defects, and zinc.

Authors: R W Hurd; B J Wilder; H A Van Rinsvelt
Journal: Lancet Date: 1983-01-22 Impact factor: 79.321

Review 4. Evidence for multi-site closure of the neural tube in humans.

Authors: M I Van Allen; D K Kalousek; G F Chernoff; D Juriloff; M Harris; B C McGillivray; S L Yong; S Langlois; P M MacLeod; D Chitayat
Journal: Am J Med Genet Date: 1993-10-01

5. Fetal valproate syndrome.

Authors: J Clayton-Smith; D Donnai
Journal: J Med Genet Date: 1995-09 Impact factor: 6.318

Review 6. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.

Authors: C Kozma
Journal: Am J Med Genet Date: 2001-01-15

2. Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study.

Authors: Amanda U Sibanyoni; Marinda Joubert; Kalaivani Naidu
Journal: S Afr J Psychiatr Date: 2022-01-31 Impact factor: 1.550

2 in total

Fetal valproate syndrome.

1. Fatal cardiac malformation in fetal valproate syndrome.

2. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.

3. Valproate, birth defects, and zinc.

Review 4. Evidence for multi-site closure of the neural tube in humans.

5. Fetal valproate syndrome.

Review 6. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.

7. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.

8. Anomalous right pulmonary artery origins in association with the fetal valproate syndrome.

9. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs.

10. Fetal valproate syndrome: is there a recognisable phenotype?

Review 1. Impact of pharmacological agents on mitochondrial function: a growing opportunity?

2. Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study.